Table 2.
Mean and standard deviation for near point of convergence and stereoacuity from previous studies.
Authors and reference numbers | Country of study | Study setting | Age | Sample size | Technique | Near point of convergence |
|
---|---|---|---|---|---|---|---|
Mean SD | Mean SD | ||||||
Break | Recovery | ||||||
Near point of convergence | |||||||
Present study | South Africa | SS | 13–18 | 1056 | PU | 6.8 ± 2.8 | 9.48 ± 3.4 |
Metsing28 | South Africa | SS | 8–13 | 112 | PU | 4.9 ± 2.3 | N/A |
Jimenez et al.13 | Spain | SS | 6–12 | 1056 | PU with RL | 6.5 ± .7 | 14.3 ± 11.2 |
Abraham et al.20 | India | SS | 10–18 | 150 | AT/PLRG | 7.17 ± 3.1 | 8.63 ± 3.2 |
Hussaindeen et al.21 | India | SS | 7–13 | 920 | PU/PL | 3 ± 3/7 ± 5.1 | 4 ± 4/10 ± 7 |
Hayes et al.16 | US | SS | KG, 3rd 6th | 297 | PU | 4.3 ± 3.4 | 7.2 ± 3.9 |
Maples et al.17 | USA | SS | 8–13 | 539 | PU | 4.2 ± 3.4 | 9.8 ± 4.0 |
Brent and David9 | USA | SS | 10–14 | 126 | PU | 5.0 ± 0.2 | N/A |
Borsting et al.18 | USA | SS | 8–13 | 14 | PU | 3.92 ± 3.9 | 6.73 ± 5.13 |
Scheiman et al.19 | USA | CS | 22–37 | 175 | PLRG | 2.3 ± 2.1 | 4.35 ± 3.2 |
Yekta et al.22 | Iran | SS | 18–35 | 382 | PU | 5.2 ± 3.6 | N/A |
Lanca and Rowe24 | Portugal | SS | 6–14 | 530 | PU | 6.0 ± 0.3 | Not reported |
Stereoacuity | |||||||
Present study | South Africa | SS | 13–18 | 1056 | Randot stereo-test | 43.9 ± 25.2 | |
Jimenez13 | Spain | SS | 6–12 | 1056 | Randot stereo-test | 22 ± 6 | |
Hussaindeen et al.21 | India | SS | 7–17 | 920 | Randot stereo-test | 40 ± 1 | |
Almubrad53 | Saudi Arabia | SS | 6–12 | 1383 | Titmus | 43.3 ± 9.2 | |
Oduntan et al.51 | Saudi Arabia | SS | 6–12 | 855 | Randot stereo-test | 25.3 ± 9.9 | |
Farvardin1 and Afarid54 | Iran | SS | 6–12 | 1000 | Randot stereo-test | 71.7 ± 54.7 | |
Guo et al.55 | China | SS | 4–18 | 5780 | Titmus | 50.2 ± 50.6 |